Zobrazeno 1 - 10
of 18
pro vyhledávání: '"François Koukoui"'
Autor:
Theo Pezel, Etienne Audureau, Jacques Mansourati, Guillaume Baudry, Ahmed Ben Driss, Florence Durup, Marie Fertin, Christian Godreuil, Julien Jeanneteau, Martin Kloeckner, François Koukoui, Lamia Kesri‐Tartière, Thierry Laperche, François Roubille, Alain Cohen‐Solal, Thibaud Damy
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1509-1521 (2021)
Abstract Aims Iron deficiency (ID) occurs in about 50% of patients with heart failure (HF). The European Society of Cardiology (ESC) recommends ID diagnostic testing in newly diagnosed patients with HF and during follow‐up, with intravenous iron su
Externí odkaz:
https://doaj.org/article/83bc588f39ed49508908549c234167ea
Autor:
François Koukoui, Franck Desmoulin, Michel Galinier, Manon Barutaut, Celine Caubère, Maria Francesca Evaristi, Gurbuz Murat, Rudolf De Boer, Matthieu Berry, Fatima Smih, Philippe Rouet
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119160 (2015)
Galectin-3 (Gal-3) is considered as a myocardial fibrosis biomarker with prognostic value in heart failure (HF). Since aldosterone is a neurohormone with established fibrotic properties, we aimed to investigate if mineralocorticoid receptor antagonis
Externí odkaz:
https://doaj.org/article/51b9bec44df146b29f7fbdab54400d17
Autor:
Fatima Smih, Franck Desmoulin, Matthieu Berry, Annie Turkieh, Romain Harmancey, Jason Iacovoni, Charlotte Trouillet, Clement Delmas, Atul Pathak, Olivier Lairez, François Koukoui, Pierre Massabuau, Jean Ferrieres, Michel Galinier, Philippe Rouet
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20414 (2011)
The preclinical stage of systolic heart failure (HF), known as asymptomatic left ventricular dysfunction (ALVD), is diagnosed only by echocardiography, frequent in the general population and leads to a high risk of developing severe HF. Large scale s
Externí odkaz:
https://doaj.org/article/b79679bb8c8747fd9da00f43ca517838
Autor:
Martin Kloeckner, Guillaume Baudry, Julien Jeanneteau, Alain Cohen-Solal, Théo Pezel, Thibaud Damy, Etienne Audureau, François Koukoui, Christian Godreuil, Marie Fertin, Ahmed Ben Driss, Thierry Laperche, Florence Durup, Jacques Mansourati, François Roubille, Lamia Kesri-Tartière
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Wiley, In press, ⟨10.1002/ehf2.13245⟩
ESC Heart Failure, Vol 8, Iss 2, Pp 1509-1521 (2021)
ESC Heart Failure, Wiley, In press, ⟨10.1002/ehf2.13245⟩
ESC Heart Failure, Vol 8, Iss 2, Pp 1509-1521 (2021)
Aims Iron deficiency (ID) occurs in about 50% of patients with heart failure (HF). The European Society of Cardiology (ESC) recommends ID diagnostic testing in newly diagnosed patients with HF and during follow‐up, with intravenous iron supplementa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d63db160d903729d2e250dd57f6317c
https://hal.archives-ouvertes.fr/hal-03153478
https://hal.archives-ouvertes.fr/hal-03153478
Autor:
Maria Francesca Evaristi, Sandra van Wijk, Serge Mazeres, Annie Turkieh, François Koukoui, Pauline Fournier, Michel Galinier, Christian Jung, Hans-Peter Brunner-La Rocca, Servane Le Page, Javed Butler, William F. Peacock, Philippe Rouet, Fatima Smih, Céline Caubère, Manon Barutaut, Franck Desmoulin, Camille Dambrin, Luc W. Eurlings, Clément Delmas
Publikováno v:
International Journal of Cardiology
International Journal of Cardiology, Elsevier, 2020, 300, pp.245-251. ⟨10.1016/j.ijcard.2019.09.032⟩
International Journal of Cardiology, 300, 245-251. Elsevier Ireland Ltd
International Journal of Cardiology, Elsevier, 2020, 300, pp.245-251. ⟨10.1016/j.ijcard.2019.09.032⟩
International Journal of Cardiology, 300, 245-251. Elsevier Ireland Ltd
Background: Insulin-like Growth Factor Binding Protein 2 (IGFBP2) showed greater heart failure (HF) diagnostic accuracy than the "grey zone" B-type natriuretic peptides, and may have prognostic utility as well.Objectives: To determine if IGFBP2 provi
Autor:
L. Bonnefous, Barnabas Gellen, Jacques Mansourati, Jean-Noël Trochu, François Roubille, Florence Beauvais, Pierre Gibelin, E. Berthelot, A. Barigou, C. Chong-Nguyen, A. Le Helloco, Diane Bodez, François Koukoui, Thibaud Damy, Mélanie Bézard, U. Vergeylen, Fabrice Bauer, Etienne Audureau, J. Gauthier, Théo Pezel
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:27-28
Background Heart Failure (HF) is a major public health problem resulting in high rates of hospitalization and mortality. Most HF Surveys have included selected HF patients and did not focus on HF life burden. Purpose To describe a large French HF pop
Autor:
Alain Cohen-Solal, Pauline Fournier, Javed Butler, William Mullen, Jerome Roncalli, Luc W. Eurlings, Franck Desmoulin, Sandra van Wijk, Céline Caubère, Maria Francesca Evaristi, Philippe Rouet, Manon Barutaut, Annie Turkieh, Fatima Smih, François Koukoui, Roger Escamilla, Clément Delmas, Hans-Peter Brunner-La Rocca, Marie-France Seronde, Harald Mischak, Michel Galinier, Matthieu Berry, Jean Ferrières
Publikováno v:
International Journal of Cardiology-Metabolic & Endocrine, 6, 5-12. Elsevier
Background: Diagnostic biomarkers for heart failure (HF) such as the natriuretic peptides (NPs) are widely used but have limitations. Innovative biomarkers could provide improved diagnostic performance. Methods: We launched a prospective case-control
Autor:
Céline Caubère, Michel Galinier, Manon Barutaut, François Koukoui, Fatima Smih, Annie Turkieh, Philippe Rouet, Romain Harmancey, Camille Dambrin
Publikováno v:
médecine/sciences. 31:31-34
Autor:
Jacques Mansourati, Pierre Gibelin, U. Vergeylen, François Roubille, C. Chong-Nguyen, Barnabas Gellen, Jean-Noël Trochu, A. Barigou, Florence Beauvais, Emmanuelle Berthelot, Fabrice Bauer, Théo Pezel, A. Le Helloco, M. Bezard, T. Damy, Etienne Audureau, Diane Bodez, François Koukoui, L. Bonnefous, J. Gauthier
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:123
Background Heart Failure (HF) is a major public health problem resulting in high rates of hospitalization and mortality. So far, most HF Surveys have included a selected population of patients with HF and involved mainly one type of cardiologic pract
Autor:
Maria Francesca Evaristi, P. Trochet, P. Fournier, François Koukoui, M. Galinier, P. Davault, F. Peacock, Céline Caubère, Manon Barutaut, Fatima Smih, Denis Calise, G. Murat, Philippe Rouet, C. Dambrin
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 10:215
Aims Metabolic syndrome (MetS) is a known risk factor for cardiovascular events. It is characterized by central obesity plus any two of dyslipidemia, insulin resistance, and hypertension. Obese and diabetic patients with MetS have low plasma insulin-